Frontotemporal Lobar Degeneration

This is a type of brain disease that causes the front and sides of the brain to shrink. It leads to changes in personality, behavior, and language. It's a progressive condition, meaning it gets worse over time.

Condition

What people with Frontotemporal Lobar Degeneration report

Every report comes from a Lived member, sent anonymously.

Have you tried Speech therapy for Frontotemporal Lobar Degeneration?

NameHow it went

About Frontotemporal Lobar Degeneration

What It Is

Frontotemporal lobar degeneration (FTLD) is a group of brain diseases in which nerve cells in the frontal and temporal lobes gradually die and those areas shrink. The frontal lobes, behind the forehead, guide planning, judgment and social behavior. The temporal lobes, at the sides of the head, are central to language and to connecting emotions with people and things. As damage spreads, people lose abilities that depend on these regions. FTLD is the biological name; the illnesses people are diagnosed with are usually called frontotemporal dementia (FTD) or frontotemporal disorders. The most common form changes personality, behavior and judgment: a person may become impulsive, tactless, withdrawn or fixated on routines or certain foods, often without realizing anything is different. In primary progressive aphasia, language goes first, with trouble finding words, understanding them or forming sentences. Other forms mainly affect movement, causing stiffness, falls or clumsy hands, and some people also develop amyotrophic lateral sclerosis (ALS), a disease of the nerves that control muscles. Unlike Alzheimer's, FTLD often leaves everyday memory relatively intact early on. It also tends to start younger: roughly 60% of people with FTD are between 45 and 64, an age when many are still working and raising families.

Causes & Risk Factors

In most people, the cause of FTLD is unknown. Inside affected nerve cells, proteins that normally help cells work (most often tau or TDP-43) build up in abnormal forms, and the cells in those regions are damaged. Why this starts is not yet understood. About one in three cases is inherited, passed from parent to child. Three genes account for most of these: MAPT, GRN and C9orf72. A variant in C9orf72 is the most common inherited cause and can lead to FTD, ALS or both. Members of the same family who carry the same variant may develop different symptoms at different ages. A family history of dementia, ALS or unexplained psychiatric illness starting in midlife is a reason to discuss genetic counseling, which can help people decide whether testing is right for them and what results would mean for relatives.

How It's Diagnosed

There is no single test for FTLD, and it is often recognized late. Early behavior changes are easily mistaken for depression or another psychiatric problem, and language or movement symptoms can look like other conditions, including Alzheimer's. In one large registry, people waited a median of about two years between first symptoms and diagnosis. An assessment usually starts with a detailed history from the person and from someone who knows them well, since the person may not notice their own changes. A neurologist or memory specialist tests thinking, language, behavior and movement, and a psychiatric evaluation can show whether depression or another condition is contributing. Blood tests help rule out other causes. MRI can show shrinkage of the frontal or temporal lobes and exclude problems such as a stroke or tumor, although the scan may look normal early on. PET scans, which show how actively brain regions are working, and tests for Alzheimer's-related proteins can help tell FTLD apart from Alzheimer's. Genetic testing can confirm an inherited form. Otherwise, the exact type of protein change can only be confirmed by examining the brain after death.

Treatment Options

There is currently no treatment that cures FTLD or slows its course, and no disease-modifying medicine has been approved. Care focuses on easing specific symptoms, keeping the person safe and engaged, and supporting the family, ideally through a team that includes a neurologist, nurses, social workers and speech, physical and occupational therapists familiar with these disorders. For behavior changes, doctors often try a selective serotonin reuptake inhibitor (SSRI), a type of antidepressant, to reduce impulsive or disinhibited behavior. Low doses of antipsychotic medicines are sometimes used for aggression or delusions. Responses vary, so medicines are often adjusted. Practical changes matter as much: a regular routine, fewer distractions, simple either-or choices instead of open questions, and supervising food or money when compulsive eating or poor judgment become problems. For language symptoms, a speech-language pathologist experienced with progressive aphasia (rather than stroke-related aphasia) can help preserve skills and introduce tools such as picture albums, gestures and phone or tablet apps. For movement symptoms, physical and occupational therapy, walking aids and sometimes Parkinson's medicines can give modest, temporary relief. Clinical trials are testing treatments aimed at specific genetic forms, especially GRN, and at tau, and people with FTLD and their relatives can ask about joining research.

What to Expect

FTLD gets worse over time, and as it spreads, symptoms of other types tend to appear: someone who began with behavior changes may develop language or movement problems, and the reverse. How fast this happens varies widely. Some people live more than 10 years after diagnosis and others less than two. In one population study, median survival after diagnosis was about four and a half years overall, longer for primary progressive aphasia and shorter for the behavioral form. People who also have ALS usually decline faster, often over two to three years, as weakness affects walking, swallowing and breathing. Because many people lack insight into their changes, they may not see why they need help, and work, driving, money and relationships are often affected before a diagnosis is made. It helps families to understand that the person cannot control these behaviors; arguing or reasoning rarely works, while calm redirection often does. Over time, the person will need increasing supervision and eventually full-time care. Caregiving for FTLD is often especially demanding because it can arrive in midlife, alongside jobs and children. Planning early, while the person can still take part, covers legal and financial decisions, work and disability benefits, and future care preferences. In the US, FTD qualifies for faster Social Security disability review under the Compassionate Allowances program. Respite care, adult day programs and FTD-specific support groups can help caregivers protect their own health.

When to Seek Help

Arrange an evaluation when a person in midlife or later shows a lasting change in personality, judgment, social behavior or language that is out of character, especially if it is affecting work, money or relationships. Ask for a specialist referral if depression treatment is not explaining or improving the changes, or if there is a family history of FTD or ALS. After a diagnosis, contact the care team promptly about new muscle weakness or twitching, coughing or choking when eating or drinking, frequent falls, or behavior that puts the person or others at risk, such as unsafe driving or reckless spending. These changes can call for a new assessment, therapy or safety plan.

Questions to Ask Your Doctor

  1. 1.Which form of frontotemporal disorder does this look like, and how confident are we in the diagnosis?
  2. 2.Should we consider genetic counseling or testing, and what would the results mean for other family members?
  3. 3.Which symptoms can treatment realistically help, and how will we judge whether a medicine is working?
  4. 4.What changes should we expect in the next year or two, and when should we plan for more care at home or elsewhere?
  5. 5.Are there clinical trials, specialist centers or support services we should connect with now?

Last reviewed • Oct 2026

Educational content, not medical advice.